• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共济失调毛细血管扩张症突变(ATM)基因错义变异的功能和计算评估:癌症风险增加的突变

Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.

作者信息

Mitui M, Nahas S A, Du L T, Yang Z, Lai C H, Nakamura K, Arroyo S, Scott S, Purayidom A, Concannon P, Lavin M, Gatti R A

机构信息

Department of Pathology and Laboratory Medicine, The David Geffen School of Medicine at the University of California, Los Angeles (UCLA), Los Angeles, California 90095-1732, USA.

出版信息

Hum Mutat. 2009 Jan;30(1):12-21. doi: 10.1002/humu.20805.

DOI:10.1002/humu.20805
PMID:18634022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2776735/
Abstract

The functional consequences of missense variants are often difficult to predict. This becomes especially relevant when DNA sequence changes are used to determine a diagnosis or prognosis. To analyze the consequences of 12 missense variants in patients with mild forms of ataxia-telangiectasia (A-T), we employed site-directed mutagenesis of ataxia-telangiectasia mutated (ATM) cDNA followed by stable transfections into a single A-T cell line to isolate the effects of each allele on the cellular phenotype. After induction of the transfected cells with CdCl2, we monitored for successful ATM transcription and subsequently assessed: 1) intracellular ATM protein levels; 2) ionizing radiation (IR)-induced ATM kinase activity; and 3) cellular radiosensitivity. We then calculated SIFT and PolyPhen scores for the missense changes. Nine variants produced little or no correction of the A-T cellular phenotype and were interpreted to be ATM mutations; SIFT/PolyPhen scores supported this. Three variants corrected the cellular phenotype, suggesting that they represented benign variants or polymorphisms. SIFT and PolyPhen scores supported the functional analyses for one of these variants (c.1709T>C); the other two were predicted to be "not tolerated" (c.6188G>A and c.6325T>G) and were classified as "operationally neutral." Genotype/phenotype relationships were compared: three deleterious missense variants were associated with an increased risk of cancer (c.6679C>T, c.7271T>G, and c.8494C>T). In situ mutagenesis represents an effective experimental approach for distinguishing deleterious missense mutations from benign or operationally neutral missense variants.

摘要

错义变体的功能后果往往难以预测。当利用DNA序列变化来确定诊断或预后时,这一点就显得尤为重要。为了分析12个错义变体对轻度共济失调毛细血管扩张症(A-T)患者的影响,我们对共济失调毛细血管扩张症突变(ATM)cDNA进行了定点诱变,随后将其稳定转染到单一的A-T细胞系中,以分离每个等位基因对细胞表型的影响。在用CdCl2诱导转染细胞后,我们监测ATM转录是否成功,随后评估:1)细胞内ATM蛋白水平;2)电离辐射(IR)诱导的ATM激酶活性;3)细胞放射敏感性。然后,我们计算了错义变化的SIFT和PolyPhen评分。九个变体对A-T细胞表型几乎没有或没有产生校正作用,被解释为ATM突变;SIFT/PolyPhen评分支持这一结论。三个变体校正了细胞表型,表明它们代表良性变体或多态性。SIFT和PolyPhen评分支持了其中一个变体(c.1709T>C)的功能分析;另外两个变体预计为“不耐受”(c.6188G>A和c.6325T>G),并被归类为“操作上中性”。比较了基因型/表型关系:三个有害的错义变体与癌症风险增加相关(c.6679C>T、c.7271T>G和c.8494C>T)。原位诱变是一种有效的实验方法,可用于区分有害的错义突变与良性或操作上中性的错义变体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9968/2776735/944747fef924/nihms133348f4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9968/2776735/72c9cfad8a84/nihms133348f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9968/2776735/8652f400c663/nihms133348f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9968/2776735/26ad31c570d8/nihms133348f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9968/2776735/944747fef924/nihms133348f4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9968/2776735/72c9cfad8a84/nihms133348f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9968/2776735/8652f400c663/nihms133348f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9968/2776735/26ad31c570d8/nihms133348f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9968/2776735/944747fef924/nihms133348f4a.jpg

相似文献

1
Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.共济失调毛细血管扩张症突变(ATM)基因错义变异的功能和计算评估:癌症风险增加的突变
Hum Mutat. 2009 Jan;30(1):12-21. doi: 10.1002/humu.20805.
2
Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutations.共济失调毛细血管扩张症患者携带 ATM 错义突变时 ATM 产物表达不足和定位异常。
Eur J Hum Genet. 2012 Mar;20(3):305-12. doi: 10.1038/ejhg.2011.196. Epub 2011 Nov 9.
3
Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.错义突变而非等位基因变异通过显性干扰改变乳腺癌患者中ATM的功能。
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):925-30. doi: 10.1073/pnas.012329699.
4
Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype.患有5762ins137和7271T→G突变的共济失调毛细血管扩张症患者细胞中残留的共济失调毛细血管扩张症突变蛋白功能,表现出较轻的表型。
J Biol Chem. 2001 Aug 10;276(32):30133-41. doi: 10.1074/jbc.M103160200. Epub 2001 May 29.
5
Mutation analysis of the ATM gene in two Chinese patients with ataxia telangiectasia.两名中国共济失调毛细血管扩张症患者的ATM基因突变分析。
J Neurol Sci. 2006 Feb 15;241(1-2):1-6. doi: 10.1016/j.jns.2005.09.001. Epub 2005 Dec 27.
6
Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study.ATM 蛋白的存在和残余激酶活性与共济失调毛细血管扩张症的表型相关:一项基因型-表型研究。
Hum Mutat. 2012 Mar;33(3):561-71. doi: 10.1002/humu.22016. Epub 2012 Jan 25.
7
Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene.共济失调毛细血管扩张症中的免疫缺陷与共济失调毛细血管扩张症突变基因中的两个无效突变的存在密切相关。
Clin Exp Immunol. 2008 Aug;153(2):214-20. doi: 10.1111/j.1365-2249.2008.03684.x. Epub 2008 May 26.
8
New mutations in the ATM gene and clinical data of 25 AT patients.ATM 基因新突变与 25 例 AT 患者的临床资料。
Neurogenetics. 2011 Nov;12(4):273-82. doi: 10.1007/s10048-011-0299-0. Epub 2011 Oct 2.
9
Rare variants in the ATM gene and risk of breast cancer.ATM 基因中的罕见变异与乳腺癌风险。
Breast Cancer Res. 2011 Jul 25;13(4):R73. doi: 10.1186/bcr2919.
10
Modeling ATM mutant proteins from missense changes confirms retained kinase activity.通过错义突变构建ATM突变蛋白模型证实其激酶活性得以保留。
Hum Mutat. 2009 Aug;30(8):1222-30. doi: 10.1002/humu.21034.

引用本文的文献

1
Reclassification of ATM Missense Variants of Uncertain Significance by Integrating Results from Systematic Functional Assays into an ACMG Points-Based Framework.通过将系统功能分析结果整合到基于美国医学遗传学与基因组学学会(ACMG)评分的框架中对意义未明的ATM错义变异进行重新分类
Clin Cancer Res. 2025 Jun 13;31(12):2426-2440. doi: 10.1158/1078-0432.CCR-24-3936.
2
Missense Mutations in Associated with Morphometric Traits and Meat Quality in Hainan Black Goats.海南黑山羊中与形态特征和肉质相关的错义突变
Animals (Basel). 2025 Feb 15;15(4):565. doi: 10.3390/ani15040565.
3
Digenic Inheritance of Mutations in Homologous Recombination Genes in Cancer Patients.

本文引用的文献

1
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?鉴定具有部分功能活性的BRCA1错义替代:潜在的中度风险变异?
Breast Cancer Res. 2007;9(6):R82. doi: 10.1186/bcr1826.
2
Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker.使用Mutalyzer序列变异命名检查器改进突变数据库和文献中的序列变异描述。
Hum Mutat. 2008 Jan;29(1):6-13. doi: 10.1002/humu.20654.
3
Systematic discovery of in vivo phosphorylation networks.
癌症患者中同源重组基因双基因遗传突变
J Pers Med. 2024 May 29;14(6):584. doi: 10.3390/jpm14060584.
4
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL.B 细胞急性淋巴细胞白血病中依妥珠单抗奥滨尤妥珠单抗应答和耐药的基因组决定因素。
Blood. 2024 Jul 4;144(1):61-73. doi: 10.1182/blood.2024023930.
5
Evaluation of Ataxia-Telangiectasia Mutated IVS10 Mutation in Breast Cancer Along with Clinicopathological Parameters.共济失调毛细血管扩张症突变基因IVS10突变在乳腺癌中的评估及其与临床病理参数的关系
J Midlife Health. 2023 Oct-Dec;14(4):272-279. doi: 10.4103/jmh.jmh_71_23. Epub 2024 Feb 23.
6
ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC.ATM 突变与 NSCLC 中独特的共突变模式和治疗弱点相关。
Clin Cancer Res. 2023 Dec 1;29(23):4958-4972. doi: 10.1158/1078-0432.CCR-23-1122.
7
Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort.单基因与膀胱癌风险关联研究的系统综述及在大型人群队列中的验证分析
BJUI Compass. 2022 Dec 7;4(2):156-163. doi: 10.1002/bco2.206. eCollection 2023 Mar.
8
Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro.抗 CD37 放射免疫疗法联合 PARP 抑制剂奥拉帕利治疗非霍奇金淋巴瘤的体外研究。
PLoS One. 2022 Apr 29;17(4):e0267543. doi: 10.1371/journal.pone.0267543. eCollection 2022.
9
Consensus Recommendations for the Clinical Management of Hematological Malignancies in Patients with DNA Double Stranded Break Disorders.DNA双链断裂障碍患者血液系统恶性肿瘤临床管理的共识性建议
Cancers (Basel). 2022 Apr 14;14(8):2000. doi: 10.3390/cancers14082000.
10
Unusual clinical manifestations and predominant stopgain ATM gene variants in a single centre cohort of ataxia telangiectasia from North India.来自印度北部单一中心队列的共济失调毛细血管扩张症患者的不常见临床表现和主要的 ATM 基因变异。
Sci Rep. 2022 Mar 8;12(1):4036. doi: 10.1038/s41598-022-08019-0.
体内磷酸化网络的系统性发现。
Cell. 2007 Jun 29;129(7):1415-26. doi: 10.1016/j.cell.2007.05.052. Epub 2007 Jun 14.
4
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.ATM和ATR底物分析揭示了对DNA损伤作出反应的广泛蛋白质网络。
Science. 2007 May 25;316(5828):1160-6. doi: 10.1126/science.1140321.
5
Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides.用反义吗啉代寡核苷酸纠正典型的ATM剪接突变和异常的ATM功能。
Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):6007-12. doi: 10.1073/pnas.0608616104. Epub 2007 Mar 26.
6
Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR).解读错义变体:比较人类疾病基因CDKN2A、MLH1、MSH2、MECP2和酪氨酸酶(TYR)中的计算方法。
Hum Mutat. 2007 Jul;28(7):683-93. doi: 10.1002/humu.20492.
7
Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility.对BRCA1、BRCA2和ATM中潜在功能性变异进行计数可预测乳腺癌易感性。
Hum Mol Genet. 2007 May 1;16(9):1051-7. doi: 10.1093/hmg/ddm050. Epub 2007 Mar 6.
8
Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry.基于人群的乳腺癌风险评估,该风险与来自乳腺癌家族登记处的ATM基因变异c.7271T>G和c.1066-6T>G(IVS10-6T>G)相关。
Hum Mutat. 2006 Nov;27(11):1122-8. doi: 10.1002/humu.20415.
9
ATM mutations in Italian families with ataxia telangiectasia include two distinct large genomic deletions.患有共济失调毛细血管扩张症的意大利家族中的 ATM 突变包括两种不同的大片段基因组缺失。
Hum Mutat. 2006 Oct;27(10):1061. doi: 10.1002/humu.9454.
10
Involvement of novel autophosphorylation sites in ATM activation.新型自磷酸化位点参与ATM激活。
EMBO J. 2006 Aug 9;25(15):3504-14. doi: 10.1038/sj.emboj.7601231. Epub 2006 Jul 13.